N-methyl-7-nitro-2,1,3-benzoxadiazol-4-amine - CAS 18378-29-5
Catalog: |
BB056361 |
Product Name: |
N-methyl-7-nitro-2,1,3-benzoxadiazol-4-amine |
CAS: |
18378-29-5 |
Synonyms: |
N-Methyl-7-nitro-2,1,3-benzoxadiazol-4-amine; N-methyl-4-nitro-2,1,3-benzoxadiazol-7-amine; 4-(Methylamino)-7-nitro-2,1,3-benzoxadiazole; Benzofurazan, 4-(methylamino)-7-nitro- |
IUPAC Name: | N-methyl-4-nitro-2,1,3-benzoxadiazol-7-amine |
Description: | N-methyl-7-nitro-2,1,3-benzoxadiazol-4-amine (cas# 18378-29-5) is a useful research chemical. |
Molecular Weight: | 194.14 |
Molecular Formula: | C7H6N4O3 |
Canonical SMILES: | CNC1=CC=C(C2=NON=C12)[N+](=O)[O-] |
InChI: | InChI=1S/C7H6N4O3/c1-8-4-2-3-5(11(12)13)7-6(4)9-14-10-7/h2-3,8H,1H3 |
InChI Key: | UAPBYPSUWZVMRV-UHFFFAOYSA-N |
Melting Point: | 258 -260°C |
Solubility: | DMSO (Slightly), Methanol (Slightly) |
Appearance: | Very Dark Orange Solid |
Storage: | -20°C Freezer, Under inert atmosphere |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P273, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
KR-101829451-B1 | Compound and composition for detecting phosgene and diethyl chlorophosphate | 20160224 |
US-2018120314-A1 | Fluorescent polybranched probes for detecting bacteria and/or fungi in vitro and in vivo | 20141113 |
US-2014296307-A1 | Potent analogues of the c-myc inhibitor 10074-g5 with improved cell permeability | 20130327 |
US-9242944-B2 | Potent analogues of the C-Myc inhibitor 10074-G5 with improved cell permeability | 20130327 |
US-2015004266-A1 | Novel compositions from Nigella sativa | 20101129 |
US-9180155-B2 | Compositions from Nigella sativa | 20101129 |
US-2012041479-A1 | Tissue Sealant Compositions, Vascular Closure Devices, and Uses Thereof | 20090427 |
US-2016331862-A1 | Tissue sealant compositions, vascular closure devices, and uses thereof | 20090427 |
US-2019192727-A1 | Tissue sealant compositions, vascular closure devices, and uses thereof | 20090427 |
US-2019192728-A1 | Tissue sealant compositions, vascular closure devices, and uses thereof | 20090427 |
PMID | Publication Date | Title | Journal |
19332372 | 20090501 | Synthesis of conjugated spermine derivatives with 7-nitrobenzoxadiazole (NBD), rhodamine and bodipy as new fluorescent probes for the polyamine transport system | Bioorganic & medicinal chemistry letters |
17464416 | 20070507 | Synthesis and characterization of a new fluorescent probe for reactive oxygen species | Organic & biomolecular chemistry |
16257275 | 20060102 | Analysis of microperoxidases using liquid chromatography, post-column substrate conversion and fluorescence detection | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences |
Complexity: | 232 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 194.04399007 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 194.04399007 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 96.8Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS